3820911000001103: Debrisoquine 10mg tablets (Cambridge Laboratories) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Debrisoquine 10mg tablets (Cambridge Laboratories)
\UK product\Virtual medicinal product\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\UK product\Virtual therapeutic moiety\Debrisoquine\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\UK product\Virtual therapeutic moiety\Debrisoquine\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)

\Medicinal product\Medicinal product categorized by structure\Product containing isoquinoline\Product containing debrisoquine\Debrisoquine\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing isoquinoline\Product containing debrisoquine\Debrisoquine\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing isoquinoline\Product containing debrisoquine\Product containing debrisoquine in oral dose form (medicinal product form)\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing debrisoquine\Debrisoquine\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing debrisoquine\Debrisoquine\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing debrisoquine\Product containing debrisoquine in oral dose form (medicinal product form)\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)
\Medicinal product\Product manufactured as oral dose form\Product containing debrisoquine in oral dose form (medicinal product form)\Product containing only debrisoquine in oral dose form (medicinal product form)\Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet\Debrisoquine 10mg tablets (Cambridge Laboratories)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17831901000001119 Debrisoquine 10mg tablets (Cambridge Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

41398501000001113 Debrisoquine 10mg tablets (Cambridge Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Is a	Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has active ingredient	Debrisoquine	false	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has active ingredient	Debrisoquine sulphate	false	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Debrisoquine	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has specific active ingredient	Debrisoquine sulphate	false	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has specific active ingredient	Debrisoquine sulfate	true	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories)	Has basis of strength substance	Debrisoquine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Debrisoquine 10mg tablets (Cambridge Laboratories) 100 tablet	Is pack of	False	Debrisoquine 10mg tablets (Cambridge Laboratories)	Inferred relationship	Existential restriction modifier
Debrisoquine 10mg tablets (Cambridge Laboratories) 100 tablet	Has AMP	True	Debrisoquine 10mg tablets (Cambridge Laboratories)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17831901000001119	Debrisoquine 10mg tablets (Cambridge Laboratories) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
41398501000001113	Debrisoquine 10mg tablets (Cambridge Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module